Trials / Completed
CompletedNCT05719688
Evaluate the Safety and Efficacy of Thrombectomy System in the Intravascular Treatment of Acute Ischemic Stroke
Prospective, Multicenter, Randomized, Parallel Controlled Study to Evaluate the Safety and Efficacy of Thrombectomy System in the Intravascular Treatment of Acute Ischemic Stroke
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 202 (actual)
- Sponsor
- Suzhou Hengruihongyuan Medical Technology Co. LTD · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Through the implementation of prospective, multi-center, randomized, parallel controlled clinical studies to verify the safety and effectiveness of Hongyuan thrombolysis device system in the intravascular treatment of acute ischemic stroke. According to the requirements of the experiment, 200 subjects were selected and randomly divided into the experimental group and the control group 1:1. According to the information of the group, corresponding devices were used to receive endovascular therapy and the results were evaluated.
Detailed description
Through the implementation of prospective, multi-center, randomized, parallel controlled clinical studies to verify the safety and effectiveness of Hongyuan thrombolysis device system in the intravascular treatment of acute ischemic stroke. According to the requirements of the trial, 200 subjects with acute ischemic stroke who met the inclusion criteria and did not meet any exclusion criteria were randomly divided into the test group and the control group at 1:1, and received endovascular therapy with corresponding instruments according to the information of the group and evaluated the results
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Mechanical thrombectomy | Treatment of ischemic stroke patients with Mechanical thrombectomy |
Timeline
- Start date
- 2022-12-16
- Primary completion
- 2023-10-31
- Completion
- 2024-05-24
- First posted
- 2023-02-09
- Last updated
- 2025-07-01
Locations
18 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05719688. Inclusion in this directory is not an endorsement.